Biostatistics Working Group
Biostatistics Working Group
Spring 1999
-- Joint modeling of longintudinal and primary endpoint data
Description:
In the study of new treatments for disease and public health,
data may be collected repeatedly over time on a number of variables,
often referred to in this context as "markers," and on an endpoint of
primary interest. For example, in the study of treatments for
HIV/AIDS, observations on immunological and virological measures may
be taken on each subject in a clinical trial repeatedly over the
course of the trial, and the primary endpoint of interest may be the
time to an event such as death or development of full-blown AIDS.
Often, a key question is whether the nature of progression of such
markers over time may be "associated with" the primary outcome
somehow. The hope is that repeated measurement of the marker over a
short term may provide information on the primary endpoint, which may
take a much longer time to be observed, thus providing rationale for
shorter studies where only repeated measurements on the marker are
made.
Much recent interest has focused on formalizing this issue, the
so-called "surrogate marker" problem, and on statistical models and
methods to address this issue via joint modeling of the repeated
measurement trajectories and the primary endpoint of interest.
Modeling and inferential strategies for longitudinal data alone and
for primary endpoints alone are well-developed; the key is unifying
these methods. Research on such joint modeling is a current "hot"
topic in the statistical literature, and the area is rapidly evolving.
These seminars provide and introduction and overview of this
problem.
Seminars and copies of slides:
Return to top .
Return to
Biostatistics Working Group